MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Bidirectional interplay between DBS and cognition in Parkinson’s disease: a systematic review

V. Sisodia, A. Malekzadeh, E. Verwijk, P. Schuurman, R. de Bie, B. Swinnen (Amsterdam, Netherlands)

Meeting: 2024 International Congress

Abstract Number: 821

Keywords: Cognitive dysfunction, Deep brain stimulation (DBS), Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: To evaluate the evidence regarding (1) deep brain stimulation (DBS) effectiveness in case of postoperative cognitive deterioration, (2) the impact of preoperative cognition on DBS effectiveness, and (3) the impact of DBS on cognition in Parkinson’s disease (PD).

Background: DBS is efficacious for treating motor symptoms in PD. However, the impact of DBS on cognition and the impact of cognition on DBS effectiveness remain unclear.

Method: Literature searches were performed on MEDLINE, EMBASE and CENTRAL (Cochrane library). Primary outcomes were OFF-drug Unified Parkinson Disease Rating Scale (UPDRS) part III score and cognitive test scores. Secondary outcomes included the ON-drug UPDRS part III score, levodopa equivalent daily dose (LEDD), and incidence of dementia.

Results: The improvement in OFF-drug and ON-drug UPDRS part III score and LEDD did not differ between patients with postoperative declining cognition compared to patients with stable cognition during follow-up (5 studies) (Figure 1). The mean difference in the OFF-drug UPDRS III score was not different (1.79 points, 95% CI -5.21 to 8.79) between patients with cognitive impairment versus patients with normal cognition at baseline (1 study). DBS moderately decreased verbal fluency compared to best medical treatment (24 studies) (Figure 2). However, this decline in verbal fluency appeared to be transient, with no statistically significant difference observed between DBS and best medical treatment 12 months after surgery. For all other cognitive domains, the decline after DBS was either small (i.e., attention/concentration and psychomotor speed) or not statistically significant. No statistically significant differences were observed in dementia incidence in the DBS group compared to best medical treatment.

Conclusion: DBS motor effectiveness in PD does not appear to be influenced by cognition. DBS in PD seems cognitively safe, except for a moderate decline in verbal fluency. Further research is warranted.

Figure 1

Figure 1

Figure 2

Figure 2

To cite this abstract in AMA style:

V. Sisodia, A. Malekzadeh, E. Verwijk, P. Schuurman, R. de Bie, B. Swinnen. Bidirectional interplay between DBS and cognition in Parkinson’s disease: a systematic review [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/bidirectional-interplay-between-dbs-and-cognition-in-parkinsons-disease-a-systematic-review/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/bidirectional-interplay-between-dbs-and-cognition-in-parkinsons-disease-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley